Tuesday, June 23, 2026 5:15 PM ET
11 hours ago
UPS to invest $48 million in cold facilities amid GLP-1 boom11 hours ago
SNAP restrictions could change what shoppers buy — and food giants are watching3 days ago
U.S. opens tariff probe targeting Germany's drug pricing policies4 days ago
What this biotech's volatile stock price tells you about the weight loss market right now4 days ago
UniQure to seek FDA approval for Huntington's disease gene therapy in reversal4 days ago
Biotech IPO revival faces competition from cash-rich big pharma buyers7 days ago
Centene to offer buyouts to some employees as health insurer cuts costs8 days ago
Drugmakers race to find a place in the next wave of obesity drugs10 days ago
CVS Health executives on reducing healthcare's biggest pain points10 days ago
Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'12 days ago
How screwworm in U.S. cattle herds could re-inflate record beef prices13 days ago
The space race is coming for pharma: Why drug development is heading to orbit13 days ago
Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion14 days ago
Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why15 days ago
GLP-1 pioneers Novo and Lilly compete on pills, prepare to pitch seniors15 days ago
Food supply 'not at risk' after new Texas screwworm cases, USDA secretary says15 days ago
Weight loss drug maker sinks 23% after new safety data spooks investors15 days ago
U.S. confirms second Texas screwworm case, Canada restricts livestock imports17 days ago
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success17 days ago
Warren Buffett disciple Guy Spier's rare cancer changed how he values everything17 days ago
An 'EpiPen' for heart attacks?: The market has yet to give this drug stock credit18 days ago
As the World Cup kicks off, health officials are focused on more than Ebola19 days ago
'Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-Covid19 days ago
Eli Lilly's top dealmaker says don't be surprised to see more M&A19 days ago
Biotech Abivax sinks 43% as cancer cases cloud trial data for bowel disease drug14 days ago
Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trial21 days ago
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare23 days ago
Replimune to resubmit twice rejected drug for approval after FDA shakeup23 days ago
Oura is launching its smallest smart ring yet, shrinking wearable design by 40%26 days ago
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans26 days ago
Amazon's top health exec is stepping down, will be replaced by Amwell co-founder26 days ago